Early outcomes after endovascular management of acute, complicated type B aortic dissection

Size: px
Start display at page:

Download "Early outcomes after endovascular management of acute, complicated type B aortic dissection"

Transcription

1 From the Society for Vascular Surgery Early outcomes after endovascular management of acute, complicated type B aortic dissection Robert J. Feezor, MD, a Tomas D. Martin, MD, b Philip J. Hess Jr, MD, b Thomas M. Beaver, MD, b Charles T. Klodell, MD, b and W. Anthony Lee, MD, a Gainesville, Fla Objectives: Surgical management of acute, complicated type B aortic dissection is associated with significant morbidity and mortality. This study examined the feasibility and safety of endovascular treatment of this pathology. Methods: We reviewed a prospectively maintained thoracic endovascular database and medical records at a single institution from 2005 to The study group comprised of acute, complicated type B dissections, defined as duration of symptoms <14 days and involving either false lumen rupture, malperfusion, intractable pain, or uncontrolled hypertension. All repairs were performed using the TAG device (W. L. Gore and Associates, Flagstaff, Ariz). Select 30-day or in-hospital outcomes were reported. Results: Of the 216 thoracic endovascular aortic aneurysm repairs performed during the study period, 33 (15%) were for acute, complicated type B dissections. There were eight women (24%). The mean age was years. The average duration of symptoms was (median, 1) days. The indications for repair included rupture in 15 patients (46%) and mesenteric/renal/lower extremity malperfusion in 11 (33%). Mean fluoroscopy time and contrast volume were minutes and ml, respectively. Eight (73%) of 11 patients with malperfusion required branch vessel stenting. The 30-day in-hospital mortality was 21% (7 of 33). Causes of death included cardiac arrest in 3, progressive multisystem organ failure in 2, rupture in 1 and unknown in 1. At least one major complication occurred in 76% of the patients, including respiratory failure in 11 (33%), permanent spinal cord ischemia in 5 (15%), renal failure requiring dialysis in 4 (12%), and stroke in 4 (12%). The mean postoperative length of stay was days, and only 14 (42%) were discharged to home. Conclusions: Emergency endovascular repair of acute, complicated type B dissection is associated with significant mortality and morbidity. The overall role of this therapy in the treatment of this lethal problem should be better defined and compared with other surgical or interventional options before being generally adopted. (J Vasc Surg 2009;49:561-7.) Aortic dissection is a relatively rare entity, with an incidence of 2.9 cases per 100,000 per year. 1 Current management of uncomplicated type B dissections is intensive medical therapy with blood pressure and pulse rate reduction using nitrates and -blockers, which has been associated with a 3-year actuarial survival of 78%. 2 However, urgent intervention is indicated when an acute dissection is complicated by malperfusion or rupture. 3,4 Treatment options have included direct aortic replacement, extra-anatomic revascularization (eg, axillary-femoral bypass) for lower extremity ischemia, and percutaneous fenestrations for visceral malperfusion. 5,6 More recently, endovascular stent graft treatment of acute aortic dissections has been used as a potentially minimally invasive alternative to conventional aortic surgery. 7 The principles of therapy involve restoration of true lumen flow with closure of the primary tear and restoration of From the Divisions of Vascular Surgery and Endovascular Therapy a and Thoracic and Cardiovascular Surgery, b University of Florida College of Medicine. Competition of interest: none. Presented at the Society for Vascular Surgery Annual Meeting, San Diego, Calif, Jun 5-8, Correspondence: W. Anthony Lee, MD, Division of Vascular Surgery and Endovascular Therapy, 1600 SW Archer Rd, Ste NG-45, PO Box , Gainesville, FL ( anthony.lee@surgery.ufl. edu) /$36.00 Copyright 2009 Published by Elsevier Inc. on behalf of The Society for Vascular Surgery. doi: /j.jvs visceral/lower extremity perfusion. Although no commercially available device in the United States is currently approved for this indication, the TAG endograft (W. L. Gore and Associates, Flagstaff, Ariz) has been used off-label in these cases. In this study, we review the early outcomes of endovascular stent graft repair of acute, complicated acute aortic dissections at a single institution. METHODS We retrospectively reviewed our prospectively maintained database of thoracic endovascular aortic repairs (TEVAR), electronic medical records, and preoperative and postoperative imaging studies at a single tertiary-care university medical center. During the 27 months between September 2005 and December 2007, 216 TEVARs were performed. Fig 1 illustrates the distribution of underlying pathologies that were treated. Of these, 33 (15%) were performed for acute (duration of symptoms 14 days), complicated DeBakey type III/Stanford type B dissections, defined as a primary tear distal to the left subclavian artery. Specific indications included rupture in 15 (46%); malperfusion in 11 (33%), comprising mesenteric in 3, renal in 3, and lower extremity in 10; intractable pain in 3 (9%), limited retrograde extension of the dissection in 2 (6%), intramural hematoma in 1 (3%), and severe hemolysis in 1 (3%; Fig 2). All repairs were performed using the TAG device (off-label). The last three indications deserve additional clarification. In the two patients with limited retrograde exten- 561

2 562 Feezor et al JOURNAL OF VASCULAR SURGERY March 2009 Fig 1. Distribution of pathologies treated with thoracic endovascular aneurysm repair during the study period. AD, Acute, complicated type B dissections; APU, aortic penetrating ulcers; BTT, blunt traumatic transections; CD, chronic dissections; dtaa, descending thoracic aortic aneurysms repaired with TAG and other devices under an investigational device exemption clinical trial; hybrid, includes both abdominal visceral and thoracic arch debranching procedures. Fig 2. Rupture from an acute type B dissection. Note the large left hemothorax, which was drained by tube thoracostomy after endovascular repair. sion, although the primary tear was distal to the left subclavian artery, the proximal extent of the dissection involved the arch but did not extend proximal to the innominate artery and the ascending aorta, which would technically make the condition a type A dissection. In these Fig 3. Multiplanar reformation of a computed tomography angiogram shows the measurements of the proximal landing zone that were used to determine anatomic suitability and endograft selection. situations, coverage of the primary tear would theoretically depressurize the false lumen proximal as well as distal to the tear. 8 Although patients with intramural hematoma are older, more commonly present with hypertension, and have radiographic features distinct from a classic aortic dissection, 9 this condition was included in the study because it may represent a forme fruste of an aortic dissection, 10 and its natural history can be accompanied by similar complications of intractable pain, progression, and rupture. 11,12 The case of severe hemolysis was an unusual indication. Extensive preoperative imaging, including color-flow Doppler transesophageal echocardiography (TEE), which demonstrated high-flow jets through several small fenestrations in the descending thoracic aorta, and consultations with hematology were obtained to exclude other potential etiologies before proceeding with treatment. Anatomic suitability was based on a reference aortic (between the left common carotid and left subclavian artery) inner diameter (intimal) 37 mm, and a centerline distance from the distal margin of the left common carotid artery to the start of the primary tear 20 mm (Fig 3). Device oversizing was based on manufacturer s instructions for use. The side of insertion of the primary introducer sheath was based on the size of the access vessels and distal extension of the dissection. Intravascular ultrasound (IVUS) was used in 27 of 33 (82%) patients to verify the preoperative anatomy and true lumen passage of the principle guidewire. TEE was not routinely used. Endograft coverage typically started at the distal margin of the left common carotid artery origin and extended

3 JOURNAL OF VASCULAR SURGERY Volume 49, Number 3 Feezor et al mm of the celiac artery. Balloon molding was avoided accept for a significant endoleak at completion angiography, and only compliant balloons were used (Coda, Cook Medical, Bloomington, Ind). A left carotid subclavian bypass was performed in the setting of a dominant left vertebral artery or a patent left internal mammary to left anterior descending artery bypass graft. Adjunctive stenting was performed based on angiographic assessment of visceral or lower extremity vessel lumen and contrast flow after deployment of the thoracic endograft and closure of the primary tear. Spinal drainage was used inconsistently either preoperatively or postoperatively based on a combination of operator preference or new-onset symptoms of spinal cord ischemia (SCI), or both. No patient presented with preoperative paraparesis or paraplegia. All patients were monitored postoperatively in the cardiac intensive care unit. For those patients who did not have spinal drainage, any evidence of lower extremity neurologic symptoms were managed with pharmacologic elevation of systolic blood pressure 160 mm Hg, fluid resuscitation, and prompt insertion of a spinal catheter 60 minutes by an on-call cardiac anesthesiologist. The spinal catheter was placed at 10 cm above the level of the heart and adjusted higher or lower depending on therapeutic effect and amount of spinal fluid drainage. Drainage was limited to 15 ml/h or 350 ml/24 h to avoid potential complications of subdural hematoma or cerebral herniation. The catheter was left to drain for 72 hours. If any degree of therapeutic effect was achieved, the catheter was clamped for another 24 hours in case symptoms returned, and then removed. Reported outcomes included 30-day or in-hospital mortality, morbidity, intraoperative procedural measures, and discharge disposition from the index hospitalization. The study was approved by the Institutional Review Board. RESULTS The mean age of the patients was years, and eight (24%) were women. The mean duration of symptoms was days (median, 1; range, 0-14 days). Immediately before repair, in the subset of patients with malperfusion, eight (73%) had an estimated glomerular filtration rate of 60 ml/min/m 2 and 5 (45%) had a lactic acid level 1.5 mmol/l. The mean diameter and length of the proximal landing zone were mm and mm, respectively, and the TAG devices were oversized at a mean of 17.3% 9.3%. The mean fractional aortic coverage (length of aorta covered/total length of thoracic aorta from left common carotid to celiac artery) was 87%. In 22 of 33 patients (67%), the proximal landing zone involved coverage of the left subclavian artery and extension to the left common carotid artery. A left carotid subclavian bypass was required in three (14%) of these 22 patients and was performed either immediately before or after the endovascular repair based on radiographic assessments of their vertebrobasilar circulation by preoperative computed tomography angiography or intraoperative angiography, or Fig 4. Thick maximum intensity projection of adjunctive aortic branch vessel stenting that was required to treat malperfusion due to residual static flaps. Note the self-expanding nitinol stent (Protégé, ev3, Plymouth, Minn) in the superior mesenteric artery and a balloon-expandable covered stent (icast, Atrium Medical, Hudson, NH) in the left renal artery. both. No symptomatic left arm ischemia occurred in the remaining 19 patients. No patient required an iliac conduit for compromised access. Mean fluoroscopy time was minutes, contrast volume was ml, overall procedure time was minutes, and estimated blood loss was ml. Right brachial catheterization was used in 10 of 33 (30%) for angiographic access when the dissection extended into the contralateral external iliac or femoral artery, or both, and precluded safe vascular entry into the true lumen. Adjunctive endovascular stenting was required in 13 (39%) using either self-expanding or balloonexpandable covered or bare-metal stents, as appropriate (Fig 4). Among the subset of 11 patients who presented with malperfusion, 73% required branch vessel stenting. By comparison, only 27% of 15 patients who underwent repair for rupture required adjunctive stenting (P.04). The locations of adjunctive stenting included the iliac artery in five cases, the mesenteric arteries in five, and the renal arteries in four.

4 564 Feezor et al JOURNAL OF VASCULAR SURGERY March 2009 Additional surgical or endovascular procedures were required in 16 patients (48%) after their endograft repair, including 6 aortic bandings (4 distally, 2 proximally and distally), 3 aortic replacements, 2 exploratory laparotomies with small bowel resections, 1 bilateral iliofemoral bypass for disrupted iliac vessels, and 2 tube thoracostomies. More specifically, aortic banding was performed to treat either a persistent false lumen flow or type I endoleak. Briefly, a 26- or 30-mm Dacron tube graft (InterVascular, Datascope, Montvale, NJ) was bi-valved, resulting in an 8- or 9.5-cmwide patch that was cut to approximate length ( desired diameter). The aorta was circumferentially exposed either at the proximal or distal landing zones of the endograft through a thoracotomy with division of one or more intercostal arteries, as necessary. The graft was wrapped around the aorta, and the ends were stapled together. The seam was gradually tightened until an epiaortic ultrasound probe detected cessation of flow. Three patients underwent direct surgical replacements of the descending thoracic aorta to treat persistent false lumen flow. One patient had a proximal endoleak associated with an ascending aortic aneurysm, and the ascending aorta and arch were replaced. In another patient, after a failed proximal banding for a persistent endoleak, the arch and proximal descending aorta were replaced with distal anastomosis performed directly to the remaining endograft. In the third patient, a distal aortic banding was complicated by a pseudoaneurysm and the aorta distal to the endograft was replaced. Exploratory laparotomies and segmental resection of small-bowel infarctions were performed in the two patients with malperfusion immediately after their endovascular repair. These were likely secondary to their initial visceral ischemia (vs intraoperative emboli). The 30-day in-hospital mortality rate was 21% (7 of 33), with a mean time to death of 19 days (median, 12; range, 1-69 days). All of the deaths occurred in those who presented initially with either malperfusion (n 2, 18%) or rupture (n 5, 33%). The causes of death were cardiac arrest in 3 (43%), progressive multisystem organ failure in 2 (29%), rupture in 1 (14%), and unknown in 1 (14%). Of the three patients who died of cardiac arrest, one was hemodynamically unstable, required escalating pharmacologic supportive care, and the family decided to withdraw support; one had persistent hypotension of unclear etiology, and one had an acute type A dissection with pericardial tamponade at autopsy. 13,14 Overall, 25 of 33 patients (76%) experienced some type of major complication. These included respiratory failure in 11 (33%), renal failure in 4 (12%), permanent SCI in 5 (15%), and stroke in 4 (12%). SCI and stroke deserve additional clarification. Six patients had preoperative and 11 had postoperative spinal drainage. No SCI developed in those who had preoperative drainage. Symptoms of lower extremity weakness developed in eight patients (24%) who did not have preoperative drainage. This was completely reversed in three patients with prompt placement of a spinal catheter, but five were left with some degree of permanent deficit. By indication, in the 11 patients with malperfusion, six never had a spinal drain (SCI developed in one, which never resolved, but a drain could not be placed due to hemodynamic instability) and five were placed postoperatively (3 for SCI: 2 reversed, 1 permanent). In the 15 patients treated for rupture, seven did not have spinal drainage, two were placed preoperatively, and six postoperatively (4 for SCI: 1 reversed, 3 permanent). All three patients with intractable pain had preoperative spinal drainage. The remaining four patients did not receive spinal drainage. No complications occurred related to spinal drainage. With regards to strokes, two patients had posterior circulation strokes, one had an anterior circulation stroke, and one had both anterior and posterior circulation strokes. In all of the patients, the repair had extended to the left common carotid artery. However, the left carotid artery flow was not compromised, and all had either a dominant right or codominant vertebral arteries and did not require preemptive subclavian artery revascularizations. The mean hospital length of stay was days (median, 11; range, 1-69 days). At discharge, only 14 (42%) of the original 33 patients were able to go home, 12 (36%) were transferred to another inpatient facility, and one (3%) left against medical advice. Postoperative imaging obtained 1 month of the TEVAR (mean, 13 days) was available in 20 patients (61%). Of these, there were seven endoleaks (35%), consisting of two type Ia and five type II-5, and 15 (75%) had complete false lumen thrombosis of the thoracic aorta. At a mean follow-up of 5.5 months, only 20 patients (61%) were alive and only 15 (45%) were living at home. DISCUSSION The early mortality rate after endovascular stent graft repair of acute, complicated aortic dissections may be up to 25%, with a significant number of complications involving bowel infarction, extremity gangrene, pneumonia, and renal failure. 16,17 Although false lumen patency has been shown to be an independent predictor of dissectionrelated death, 21 endovascular therapy for aortic dissection has been associated with only a 75% rate of false lumen thrombosis. 19 Alternative techniques to treat malperfusion syndromes have included primary percutaneous fenestrations with or without adjunctive branch vessel stenting. In a review of 165 cases of renal malperfusion treated with this technique, Barnes et al 22 reported a mortality rate of 21%. Using a variety of endovascular stenting or fenestration, or both, Slonim et al 23 reported a mortality of 25% despite a successful revascularization rate of 93%. Endovascular stent graft repair of complicated acute dissections may offer several theoretic advantages over other catheter-directed therapies such as primary percutaneous fenestrations. Endograft repair aims to restore the native aortic anatomy by closure of the primary tear, redirection of blood flow through the true lumen, and depressurization of the false lumen. Percutaneous fenestration, in contrast, aims to increase true lumen perfusion by equalizing the pressures in both lumens by creating additional tears in the flap, but does not address the underlying

5 JOURNAL OF VASCULAR SURGERY Volume 49, Number 3 Feezor et al 565 anatomic abnormality of the dissection itself. In the era of endograft therapy, we believe that the role of percutaneous fenestrations should be limited to those patients who lack a suitable proximal landing zone or complex multilumen dissections that are not corrected by closure of the primary tear. Similarly, extra-anatomic surgical revascularizations only address the ischemic complication without treatment of the dissection itself. In both of these treatment modalities, the patient still faces an ongoing risk of rupture or extension of the dissection, which could result in recurrent malperfusion and late aneurysmal degeneration of the false lumen. Despite the minimally invasive nature of endovascular repair, the early mortality (21%) and morbidity (76%) associated with this therapy was not insignificant. The favorable early clinical results of endovascular repair seen for elective repairs of atherosclerotic, degenerative thoracic aortic aneurysms have not been mirrored in the current series. Clearly, this is related to the compromised pathophysiology of these patients at the time of their initial presentation and the unavailability of a suitable endograft system that is able to accommodate some of the unique anatomic issues that involve aortic dissections. In a single-center review of acute, complicated aortic dissections managed by a variety of techniques, the mortality rate of those who presented with malperfusion (28%) was much higher than those who did not (23% vs 16%, P.26). One-third of the patients who presented with malperfusion in this series were managed with peripheral intervention alone (including percutaneous fenestration, branch vessel stenting, or surgical bypass), whereas the remainder were treated medically or had direct aortic replacements. The mortality rates for patients treated with peripheral intervention were lower than those who underwent aortic therapy (12% vs 28%, P.19). 24 Duebener et al 18 reviewed a series of patients who underwent endografting for acute type B dissections and found an overall mortality rate of 20%, although there was no mortality among the two patients presenting with rupture. 18 In a study by Verhoye et al 20 involving 16 patients with complicated type B aortic dissections who had endovascular repairs, early mortality was 25%, and fully half of the deaths were attributable to ruptures. Our practice has been to routinely cover most of the descending thoracic aorta and an average of 87% of the aorta was covered in this series. The issue of how much of the thoracic aorta should be covered (proximal tear alone vs entire dissected segment) remains controversial. The disadvantages of extended aortic coverage include increased cost of additional devices, risk of SCI, procedural time, and contrast volume. On the other hand, our rationale was as follows: 1. Although the primary tear is often the focus of endovascular treatment, in reality, numerous re-entry tears are present throughout the descending and thoracoabdominal aorta, many of which are not always seen with preoperative CT/MR or intraoperative angiographic or IVUS imaging. 2. The hemodynamic significance of these re-entry tears cannot be assessed by any straightforward means, and closure of the primary tear may simply transfer the role of primary false lumen perfusion to one or more of these re-entry tears. 3. False-lumen thrombosis occurs up to the distal extent of the endograft coverage. 4. Although it stands to reason that extent of aortic coverage is related to SCI, because a proportion of intercostal perfusion (especially the distal segments T8 to T12) is often maintained by the false lumen, which invariably remains patent in the perioperative period due to the re-entry tears that occur opposite the abdominal branch vessels, the correlation between aortic coverage and SCI may not be as strong in the setting of dissections as it may be in degenerative, atherosclerotic pathologies. In the current study, SCI developed in nearly a quarter of those who did not receive prophylactic spinal drainage, two-thirds of whom were left with permanent deficits even after prompt placement of a spinal drain. Based on this study and observations made of our entire TEVAR practice, we now place prophylactic drains in those patients (1) requiring 15 cm thoracic aortic coverage, (2) coverage of the last 5 cm of the distal thoracic aorta, (3) who do not have coagulopathy, and (4) who are hemodynamically stable. Postoperatively, although theoretically more physiologic, we have not routinely monitored intrathecal pressures for regulation of spinal drainage but have only used volumetric measures. To date, significant complications have not occurred from this approach. CONCLUSIONS Emergency endovascular repair of acute, complicated type B aortic dissections may be feasible, with outcomes that seem comparable with other therapies; however, these repairs are technically challenging and are still associated with significant mortality and morbidity, which is likely reflective of the pathophysiology of the underlying disease. The overall role of this therapy relative to other established surgical or interventional options remains to be better defined before its generalized adoption in the treatment of acute aortic dissections. AUTHOR CONTRIBUTIONS Conception and design: RF, WL Analysis and interpretation: RF, WL Data collection: RF, WL Writing the article: RF, WL Critical revision of the article: RF, TM, PH, TB, CK, WL Final approval of the article: RF, TM, PH, TB, CK, WL Statistical analysis: RF, WL Obtained funding: Not applicable Overall responsibility: WL

6 566 Quinones-Baldrich JOURNAL OF VASCULAR SURGERY March 2009 REFERENCES 1. Mészáros I, Mórocz J, Szlávi J, Schmidt J, Tornóci L, Nagy L, et al. Epidemiology and clinicopathology of aortic dissection. Chest 2000; 117: Tsai TT, Fattori R, Trimarchi S, Isselbacher E, Myrmel T, Evangelista A, et al. Long-term survival in patients presenting with type B acute aortic dissection: insights from the International Registry of Acute Aortic Dissection. Circulation 2006;114: Atkins MD Jr, Black JH 3rd, Cambria RP. Aortic dissection: perspectives in the era of stent-graft repair. J Vasc Surg 2006;43(suppl A):30A- 43A. 4. Xu SD, Huang FJ, Yang JF, Li ZZ, Wang XY, Zhang ZG, et al. Endovascular repair of acute type B aortic dissection: early and mid-term results. J Vasc Surg 2006;43: Pradhan S, Elefteriades JA, Sumpio BE. Utility of the aortic fenestration technique in the management of acute aortic dissections. Ann Thorac Cardiovasc Surg 2007;13: Svensson LG, Kouchoukos NT, Miller DC, Bavaria JE, Coselli JS, Curi MA, et al. Expert consensus document on the treatment of descending thoracic aortic disease using endovascular stent-grafts. Ann Thorac Surg 2008;85:S Golledge J, Eagle KA. Acute aortic dissection. Lancet 2008;372: Kato N, Shimono T, Hirano T, Ishida M, Yada I, Takeda K. Transluminal placement of endovascular stent-grafts for the treatment of type A aortic dissection with an entry tear in the descending thoracic aorta. J Vasc Surg 2001;34: Coady MA, Rizzo JA, Elefteriades JA. Pathologic variants of thoracic aortic dissections. Penetrating atherosclerotic ulcers and intramural hematomas. Cardiol Clin 1999;17: Evangelista A, Mukherjee D, Mehta RH, O Gara PT, Fattori R, Cooper JV, et al. Acute intramural hematoma of the aorta: a mystery in evolution. Circulation 2005;111: Nienaber CA, von Kodolitsch Y, Petersen B, Loose R, Helmchen U, Haverich A, et al. Intramural hemorrhage of the thoracic aorta. Diagnostic and therapeutic implications. Circulation 1995;92: Vilacosta I, San Roman JA, Ferreiros J, Aragoncillo P, Méndez R, Castillo JA, et al. Natural history and serial morphology of aortic intramural hematoma: a novel variant of aortic dissection. Am Heart J 1997;134: Kpodonu J, Preventza O, Ramaiah VG, Shennib H, Wheatley GH 3rd, Rodriquez-Lopez J, et al. Retrograde type A dissection after endovascular stenting of the descending thoracic aorta. Is the risk real? Eur J Cardiothorac Surg 2008;33: Neuhauser B, Czermak BV, Fish J, Perkmann R, Jaschke W, Chemelli A, et al. Type A dissection following endovascular thoracic aortic stent-graft repair. J Endovasc Ther 2005;12: Acosta S, Blomstrand D, Gottsater A. Epidemiology and long-term prognostic factors in acute type B aortic dissection. Ann Vasc Surg 2007;21: Böckler D, Schumacher H, Ganten M, von Tengg-Kobligk H, Schwarzbach M, Fink C, et al. Complications after endovascular repair of acute symptomatic and chronic expanding Stanford type B aortic dissections. J Thorac Cardiovasc Surg 2006;132: Dake MD, Kato N, Mitchell RS, Semba CP, Razavi MK, Shimono T, et al. Endovascular stent-graft placement for the treatment of acute aortic dissection. N Engl J Med 1999;340: Duebener LF, Lorenzen P, Richardt G, Misfeld M, Nötzold A, Hartmann F, et al. Emergency endovascular stent-grafting for lifethreatening acute type B aortic dissections. Ann Thorac Surg 2004; 78: Eggebrecht H, Nienaber CA, Neuhäuser M, Baumgart D, Kische S, Schmermund A, et al. Endovascular stent-graft placement in aortic dissection: a meta-analysis. Eur Heart J 2006;27: Verhoye JP, Miller DC, Sze D, Dake MD, Mitchell RS. Complicated acute type B aortic dissection: midterm results of emergency endovascular stent-grafting. J Thorac Cardiovasc Surg 2008;136: Akutsu K, Nejima J, Kiuchi K, Sasaki K, Ochi M, Tanaka K, et al. Effects of the patent false lumen on the long-term outcome of type B acute aortic dissection. Eur J Cardiothorac Surg 2004;26: Barnes DM, Williams DM, Dasika NL, Patel HJ, Weder AB, Stanley JC, et al. A single-center experience treating renal malperfusion after aortic dissection with central aortic fenestration and renal artery stenting. J Vasc Surg 2008;47: Slonim SM, Miller DC, Mitchell RS, Semba CP, Razavi MK, Dake MD. Percutaneous balloon fenestration and stenting for life-threatening ischemic complications in patients with acute aortic dissection. J Thorac Cardiovasc Surg 1999;117: Lauterbach SR, Cambria RP, Brewster DC, Gertler JP, Lamuraglia GM, Isselbacher EM, et al. Contemporary management of aortic branch compromise resulting from acute aortic dissection. J Vasc Surg 2001;33: Submitted May 21, 2008; accepted Sep 17, INVITED COMMENTARY William J. Quinones-Baldrich, MD, Los Angeles, Calif Patients presenting with complicated type B aortic dissection represent the highest risk group of all patients with acute type B dissection. Medical management remains the preferred method of treatment for patients without complications such as intractable pain, malperfusion, or rupture. Surgical treatment of complicated type B aortic dissection improves the outcome compared with medical therapy but is still associated with significant mortality (15% to 30%). 1 The authors have presented a relatively large, well-analyzed experience on the management of patients with complicated type B aortic dissection primarily treated with an endovascular approach. Additional surgical or endovascular procedures were required in almost 50% of patients (hybrid procedure). This included six aortic bandings; it remains to be seen whether this particular combination is an effective treatment on long-term follow-up. All deaths occurred in patients with either rupture or malperfusion, underscoring the high risk in this cohort. These results suggest that a primary endovascular approach is a promising alternative to manage acute type B dissection in the absence of malperfusion or rupture. The morbidity and mortality reported in this series is comparable with contemporary results with the standard surgical approach. Survival for the endovascular approach, however, was only 61% at 5.5 months. Persistent endoleaks (35%) and false lumen patency (25%) threaten long-term results. The authors have appropriately concluded that the overall role of endovascular treatment for complicated acute type B aortic dissection remains to be better defined. Most reports of endovascular treatment of thoracoabdominal aortic pathology identify two elements that are associated with spinal cord ischemia: hypotension and lack of spinal catheter drainage. Spinal cord ischemia did not develop in any patients in this series with preoperative spinal catheter drainage (SCD), but it did occur in 24% of patients without preoperative SCD. The method used by the authors for SCD was based on volume, not pressure. In 1994 Safi and associates concluded that maintaining intraspinal pressure 15 mm Hg was key in their improved results compared with the previous experience when SCD was limited to a certain volume (50 ml). 2 Thus, a preferred approach for SCD is to continuously monitor intraspinal pressure, keeping it 15 mm Hg (10 mm Hg at our institution) at all times. The authors now recommend that SCD be used in patients who require 15 cm of thoracic aortic coverage and in those who will have coverage of

Acute dissections of the descending thoracic aorta (Debakey

Acute dissections of the descending thoracic aorta (Debakey Endovascular Treatment of Acute Descending Thoracic Aortic Dissections Nimesh D. Desai, MD, PhD, and Joseph E. Bavaria, MD Acute dissections of the descending thoracic aorta (Debakey type III or Stanford

More information

Neurological Complications of TEVAR. Frank J Criado, MD. Union Memorial-MedStar Health Baltimore, MD USA

Neurological Complications of TEVAR. Frank J Criado, MD. Union Memorial-MedStar Health Baltimore, MD USA ISES Online Neurological Complications of Frank J Criado, MD TEVAR Union Memorial-MedStar Health Baltimore, MD USA frank.criado@medstar.net Paraplegia Incidence is 0-4% after surgical Rx of TAAs confined

More information

Malperfusion Syndromes Type B Aortic Dissection with Malperfusion

Malperfusion Syndromes Type B Aortic Dissection with Malperfusion Malperfusion Syndromes Type B Aortic Dissection with Malperfusion Jade S. Hiramoto, MD, MAS April 27, 2012 Associated with early mortality Occurs when there is end organ ischemia secondary to aortic branch

More information

Combined Endovascular and Surgical Repair of Thoracoabdominal Aortic Pathology: Hybrid TEVAR

Combined Endovascular and Surgical Repair of Thoracoabdominal Aortic Pathology: Hybrid TEVAR Combined Endovascular and Surgical Repair of Thoracoabdominal Aortic Pathology: Hybrid TEVAR William J. Quinones-Baldrich MD Professor of Surgery Director UCLA Aortic Center UCLA Medical Center Los Angeles,

More information

Management of Acute Aortic Syndromes. M. Grabenwoger, MD Dept. of Cardiovascular Surgery Hospital Hietzing, Vienna, Austria

Management of Acute Aortic Syndromes. M. Grabenwoger, MD Dept. of Cardiovascular Surgery Hospital Hietzing, Vienna, Austria Management of Acute Aortic Syndromes M. Grabenwoger, MD Dept. of Cardiovascular Surgery Hospital Hietzing, Vienna, Austria I have nothing to disclose. Acute Aortic Syndromes Acute Aortic Dissection Type

More information

Challenges. 1. Sizing. 2. Proximal landing zone 3. Distal landing zone 4. Access vessels 5. Spinal cord ischemia 6. Endoleak

Challenges. 1. Sizing. 2. Proximal landing zone 3. Distal landing zone 4. Access vessels 5. Spinal cord ischemia 6. Endoleak Disclosure I have the following potential conflicts of interest to report: Consulting: Medtronic, Gore Employment in industry Stockholder of a healthcare company Owner of a healthcare company Other(s)

More information

Indications for stent grafts in type B aortic dissection

Indications for stent grafts in type B aortic dissection expert opinion I Akin C A Nienaber Indications for stent grafts in type B aortic dissection ibrahim akin christoph a nienaber Department of Medicine, Divisions of Cardiology, Pulmology and Intensive Care

More information

TEVAR for complicated acute type B dissection with malperfusion

TEVAR for complicated acute type B dissection with malperfusion Masters of Cardiothoracic Surgery TEVR for complicated acute type dissection with malperfusion Guido H.W. van ogerijen 1, David M. Williams 2, Himanshu J. Patel 1 Departments of 1 Cardiac Surgery and 2

More information

Open fenestration for complicated acute aortic B dissection

Open fenestration for complicated acute aortic B dissection Art of Operative Techniques Open fenestration for complicated acute aortic B dissection Santi Trimarchi 1, Sara Segreti 1, Viviana Grassi 1, Chiara Lomazzi 1, Marta Cova 1, Gabriele Piffaretti 2, Vincenzo

More information

Understanding the Predictors of Aneurysmal Degeneration in Type B Dissection

Understanding the Predictors of Aneurysmal Degeneration in Type B Dissection Understanding the Predictors of Aneurysmal Degeneration in Type B Dissection A case example illustrating when early endovascular intervention may provide the best outcome. BY DITTMAR BÖCKLER, MD, PhD;

More information

Development of Stent Graft. Kato et al. Development of an expandable intra-aortic prothesis for experimental aortic dissection.

Development of Stent Graft. Kato et al. Development of an expandable intra-aortic prothesis for experimental aortic dissection. Development of Stent Graft Kato et al. Development of an expandable intra-aortic prothesis for experimental aortic dissection. ASAIO J 1993 The New England Journal of Medicine Downloaded from nejm.org

More information

Percutaneous Approaches to Aortic Disease in 2018

Percutaneous Approaches to Aortic Disease in 2018 Percutaneous Approaches to Aortic Disease in 2018 Wendy Tsang, MD, SM Assistant Professor, University of Toronto Toronto General Hospital, University Health Network Case 78 year old F Lower CP and upper

More information

Performance of the conformable GORE TAG device in Type B aortic dissection from the GORE GREAT real world registry

Performance of the conformable GORE TAG device in Type B aortic dissection from the GORE GREAT real world registry University of Milan Thoracic Aortic Research Center Performance of the conformable GORE TAG device in Type B aortic dissection from the GORE GREAT real world registry Santi Trimarchi, MD, PhD Associate

More information

No Disclosure. Aortic Dissection in Japan. This. The Challenge of Acute and Chronic Type B Aortic Dissections with Endovascular Aortic Repair

No Disclosure. Aortic Dissection in Japan. This. The Challenge of Acute and Chronic Type B Aortic Dissections with Endovascular Aortic Repair No Disclosure The Challenge of Acute and Chronic Type B Aortic Dissections with Endovascular Aortic Repair Toru Kuratani Department of Cardiovascular Surgery Osaka University Graduate School of Medicine,

More information

UC SF. Disclosures. Thoracic Endovascular Aortic Repair 4/24/2009. Management of Acute Dissections: Is There Still a Role for Open Surgery?

UC SF. Disclosures. Thoracic Endovascular Aortic Repair 4/24/2009. Management of Acute Dissections: Is There Still a Role for Open Surgery? UC SF Management of Acute Dissections: Is There Still a Role for Open Surgery? Darren B. Schneider, M.D. Assistant Professor of Surgery and Radiology Division of Vascular Surgery University of California

More information

Do the Data Support Endovascular Therapy for Descending Thoracic AD? Woong Chol Kang, M.D.

Do the Data Support Endovascular Therapy for Descending Thoracic AD? Woong Chol Kang, M.D. Do the Data Support Endovascular Therapy for Descending Thoracic AD? Woong Chol Kang, M.D. Gil Hospital, Gachon University Incheon, Korea Classification of AD Acute vs. Chronic (2weeks) (IIIa, b) type

More information

Abdominal and thoracic aneurysm repair

Abdominal and thoracic aneurysm repair Abdominal and thoracic aneurysm repair William A. Gray MD Director, Endovascular Intervention Cardiovascular Research Foundation Columbia University Medical Center Abdominal Aortic Aneurysm Endografts

More information

TEVAR. (Thoracic Endovascular Aortic Repair) for Aneurysm and Dissection. Bruce Tjaden MD Vascular Surgery Fellow

TEVAR. (Thoracic Endovascular Aortic Repair) for Aneurysm and Dissection. Bruce Tjaden MD Vascular Surgery Fellow Department of Cardiothoracic & Vascular Surgery McGovern Medical School / The University of Texas Health Science Center at Houston TEVAR (Thoracic Endovascular Aortic Repair) for Aneurysm and Dissection

More information

Extent of Aortic Coverage and Incidence of Spinal Cord Ischemia After Thoracic Endovascular Aneurysm Repair

Extent of Aortic Coverage and Incidence of Spinal Cord Ischemia After Thoracic Endovascular Aneurysm Repair Extent of Aortic Coverage and Incidence of Spinal Cord Ischemia After Thoracic Endovascular Aneurysm Repair Robert J. Feezor, MD, Tomas D. Martin, MD, Philip J. Hess Jr, MD, Michael J. Daniels, ScD, Thomas

More information

Advances in Treatment of Traumatic Aortic Transection

Advances in Treatment of Traumatic Aortic Transection Advances in Treatment of Traumatic Aortic Transection Himanshu J. Patel MD University of Michigan Medical Center Author Disclosures Consulting fees from WL Gore Inc. There is no disease more conducive

More information

Transluminal Stent-graft Placement endovascular surgery

Transluminal Stent-graft Placement endovascular surgery 13 545 551 2004 Transluminal Stent-graft Placement endovascular surgery 1 1 2 2 1 1 1 3 2 1 1996 11Transluminal Stent-graft Placement TSGP 6 82 TSGP T42 O TSGP Th10 T 26 O 5 T 3 O 23T 6 O 2 T 47 A15B17B15O

More information

Endovascular therapy for Ischemic versus Nonischemic complicated acute type B aortic dissection (catbad).

Endovascular therapy for Ischemic versus Nonischemic complicated acute type B aortic dissection (catbad). Endovascular therapy for Ischemic versus Nonischemic complicated acute type B aortic dissection (catbad). AS. Eleshra, MD 1, T. Kölbel, MD, PhD 1, F. Rohlffs, MD 1, N. Tsilimparis, MD, PhD 1,2 Ahmed Eleshra

More information

Hybrid Repair of a Complex Thoracoabdominal Aortic Aneurysm

Hybrid Repair of a Complex Thoracoabdominal Aortic Aneurysm Hybrid Repair of a Complex Thoracoabdominal Aortic Aneurysm Virendra I. Patel MD MPH Assistant Professor of Surgery Massachusetts General Hospital Division of Vascular and Endovascular Surgery Disclosure

More information

Acute Type B dissection. Closure of the infra diaphragmatic tear: how and when?

Acute Type B dissection. Closure of the infra diaphragmatic tear: how and when? Acute Type B dissection. Closure of the infra diaphragmatic tear: how and when? Prof. Olgierd Rowiński II Department of Clinical Radiology Medical University of Warsaw Disclosure Speaker name: Olgierd

More information

The Petticoat Technique Managing Type B Dissection with both Early and Long Term Considerations

The Petticoat Technique Managing Type B Dissection with both Early and Long Term Considerations The Petticoat Technique Managing Type B Dissection with both Early and Long Term Considerations Joseph V. Lombardi, MD Professor & Chief, Division of Vascular & Endovascular Surgery Department of Surgery,

More information

Treatment of acute type B aortic dissection: Current status

Treatment of acute type B aortic dissection: Current status MEET Cannes, 18. - 21.06.2009 Treatment of acute type B aortic dissection: Current status Christoph A. Nienaber, MD, FACC University of Rostock Department of Internal Medicine, Cardiology christoph.nienaber@med.uni-rostock.de

More information

UC SF An Algorithm to Choose Which Uncomplicated (Asymptomatic) Acute Type B Dissection Patients Should Undergo TEVAR. Disclosures.

UC SF An Algorithm to Choose Which Uncomplicated (Asymptomatic) Acute Type B Dissection Patients Should Undergo TEVAR. Disclosures. An Algorithm to Choose Which Uncomplicated (Asymptomatic) Acute Type B Dissection Patients Should Undergo TEVAR Disclosures Royalties and research grant support from Cook Medical, Inc. Jade S. Hiramoto,

More information

Vascular Intervention

Vascular Intervention 10 : 389-393, 2001 B Vascular Intervention 1 1 2 1 1 1 1 3 2 1 1997 7 2000 4 B 29 19 10 50 84 66.1 stent graft S/G primary entry stenting S/G 12 4 2 1 1 40 mm 8 1 MOF 1 endoleak + 11 91.6% 10 stenting

More information

Aggressive Resection/Reconstruction of the Aortic Arch in Type A Dissection

Aggressive Resection/Reconstruction of the Aortic Arch in Type A Dissection Aggressive Resection/Reconstruction of the Aortic Arch in Type A Dissection M. Grabenwoger Dept. of Cardiovascular Surgery Hospital Hietzing Vienna, Austria Disclosure Statement Consultant of Jotec, Hechingen,

More information

I-Hui Wu, M.D. Ph.D. Clinical Assistant Professor Cardiovascular Surgical Department National Taiwan University Hospital

I-Hui Wu, M.D. Ph.D. Clinical Assistant Professor Cardiovascular Surgical Department National Taiwan University Hospital Comparisons of Aortic Remodeling and Outcomes after Endovascular Repair of Acute and Chronic Complicated Type B Aortic Dissections I-Hui Wu, M.D. Ph.D. Clinical Assistant Professor Cardiovascular Surgical

More information

Development of a Branched LSA Endograft & Ascending Aorta Endograft

Development of a Branched LSA Endograft & Ascending Aorta Endograft Development of a Branched LSA Endograft & Ascending Aorta Endograft Frank R. Arko III, MD Sanger Heart & Vascular Institute Carolinas Medical Center Charlotte, North Carolina, USA Disclosures Proximal

More information

Emergency Endovascular Stent-Grafting for Life-Threatening Acute Type B Aortic Dissections

Emergency Endovascular Stent-Grafting for Life-Threatening Acute Type B Aortic Dissections Emergency Endovascular Stent-Grafting for Life-Threatening Acute Type B Aortic Dissections Lennart F. Duebener, MD, Peter Lorenzen, MD, Gert Richardt, MD, Martin Misfeld, MD, Axel Nötzold, MD, Franz Hartmann,

More information

Thoracic Endovascular Aortic Repair (TEVAR) Indications and Basic Procedure

Thoracic Endovascular Aortic Repair (TEVAR) Indications and Basic Procedure Thoracic Endovascular Aortic Repair (TEVAR) Indications and Basic Procedure Tilo Kölbel, MD, PhD University Heart Center Hamburg University Hospital Eppendorf Disclosure Speaker name: Tilo Kölbel, MD I

More information

State of Art Hybrid Approach

State of Art Hybrid Approach State of Art Hybrid Approach for Complex Aorta Diseases Won Ho Kim, MD Division of Cardiology, Eulji University Hospital Eulji University School of Medicine, Daejeon, Korea Introduction.Hybrid procedure

More information

AORTIC DISSECTIONS Current Management. TOMAS D. MARTIN, MD, LAT Professor, TCV Surgery Director UF Health Aortic Disease Center University of Florida

AORTIC DISSECTIONS Current Management. TOMAS D. MARTIN, MD, LAT Professor, TCV Surgery Director UF Health Aortic Disease Center University of Florida AORTIC DISSECTIONS Current Management TOMAS D. MARTIN, MD, LAT Professor, TCV Surgery Director UF Health Aortic Disease Center University of Florida DISCLOSURES Terumo Medtronic Cook Edwards Cryolife AORTIC

More information

Subject: Endovascular Stent Grafts for Disorders of the Thoracic Aorta

Subject: Endovascular Stent Grafts for Disorders of the Thoracic Aorta 02-33000-29 Original Effective Date: 04/15/03 Reviewed: 07/26/18 Revised: 08/15/18 Subject: Endovascular Stent Grafts for Disorders of the Thoracic Aorta THIS MEDICAL COVERAGE GUIDELINE IS NOT AN AUTHORIZATION,

More information

How to manage the left subclavian and left vertebral artery during TEVAR

How to manage the left subclavian and left vertebral artery during TEVAR How to manage the left subclavian and left vertebral artery during TEVAR Jürg Schmidli Chief of Vascular Surgery Inselspital Hamburg 2017 Dept Cardiovascular Surgery, Bern, Switzerland Disclosure No Disclosures

More information

EVAR and TEVAR: Extending Their Use for Rupture and Traumatic Injury. Conflict of Interest. Hypotensive shock 5/5/2014. none

EVAR and TEVAR: Extending Their Use for Rupture and Traumatic Injury. Conflict of Interest. Hypotensive shock 5/5/2014. none EVAR and TEVAR: Extending Their Use for Rupture and Traumatic Injury Bruce H. Gray, DO MSVM FSCAI Professor of Surgery/Vascular Medicine USC SOM-Greenville Greenville, South Carolina none Conflict of Interest

More information

Type B Dissection Sub-Categories

Type B Dissection Sub-Categories Disclosure Nothing to disclose Type B Dissection On Whom to Operate on and When to do it Charles Eichler Professor, Department of Surgery Division of Vascular and Endovascular Surgery University of California

More information

1 7 central operation SMA SMA

1 7 central operation SMA SMA 12 521 527 2003 198913 Stanford A 159 8 5.0 B 139 6 4.3 A SMA SMA A 8 1 7 central operation 3 1 SMA 1 1 5 1 14 8 3 38 B 6 1 5 2 +SMA 3 1 0 2910.3 SMA 3 50 A 5 B 5 SMA SMA SMA SMA SMA 12 521 527 2003 SMA

More information

Paraplegia in endovascular repair of TAA and in TEVAR: Incidence, prevention and therapy. Johannes Lammer Medical University Vienna, Austria

Paraplegia in endovascular repair of TAA and in TEVAR: Incidence, prevention and therapy. Johannes Lammer Medical University Vienna, Austria Paraplegia in endovascular repair of TAA and in TEVAR: Incidence, prevention and therapy Johannes Lammer Medical University Vienna, Austria Conflict of interests: none 68y, male, PAU in coral reef aorta,

More information

Dissection de type B: l étude Instead et corollaire stratégique

Dissection de type B: l étude Instead et corollaire stratégique Dissection de type B: l étude Instead et corollaire stratégique Christoph A. Nienaber, MD, FACC University Rostock Heartcenter Med. Clinic I Cardiology christoph.nienaber@med.uni-rostock.de Type B aortic

More information

Animesh Rathore, MD 4/22/17. The Great Debate 45yo Man With Uncomplicated Acute TBAD: The Case For Medical Management

Animesh Rathore, MD 4/22/17. The Great Debate 45yo Man With Uncomplicated Acute TBAD: The Case For Medical Management Animesh Rathore, MD 4/22/17 The Great Debate 45yo Man With Uncomplicated Acute TBAD: The Case For Medical Management Disclosures Just a young vascular surgeon who would like to keep his job My opponent

More information

Santi Trimarchi, MD, PhD Vascular Surgeon Thoracic Aortic Research Center, Director IRCCS Policlinico San Donato University of Milan

Santi Trimarchi, MD, PhD Vascular Surgeon Thoracic Aortic Research Center, Director IRCCS Policlinico San Donato University of Milan The Gore GREAT Registry: Update about a real life data collection Santi Trimarchi, MD, PhD Vascular Surgeon Thoracic Aortic Research Center, Director IRCCS Policlinico San Donato University of Milan Disclosures

More information

Intravascular Ultrasound in the Treatment of Complex Aortic Pathologies. Naixin Kang, M.D. Vascular Surgery Fellow April 26 th, 2018

Intravascular Ultrasound in the Treatment of Complex Aortic Pathologies. Naixin Kang, M.D. Vascular Surgery Fellow April 26 th, 2018 Intravascular Ultrasound in the Treatment of Complex Aortic Pathologies Naixin Kang, M.D. Vascular Surgery Fellow April 26 th, 2018 DISCLOSURES Nothing To Disclose 2 ENDOVASCULAR AORTIC INTERVENTION Improved

More information

Global Evidence for the Treatment of Type B Aortic Dissection

Global Evidence for the Treatment of Type B Aortic Dissection Global Evidence for the Treatment of Type B Aortic Dissection Ross Milner, MD Professor of Surgery Director, Center for Aortic Diseases September 17, 2016 Disclosures Consultant Cook, Endospan, Medtronic,

More information

Aortic CT: Intramural Hematoma. Leslie E. Quint, M.D.

Aortic CT: Intramural Hematoma. Leslie E. Quint, M.D. Aortic CT: Intramural Hematoma Leslie E. Quint, M.D. 43 M Mid back pain X several months What type of aortic disease? A. Aneurysm with intraluminal thrombus B. Chronic dissection with thrombosed false

More information

Animesh Rathore, MD 4/21/17. Penetrating atherosclerotic ulcers of aorta

Animesh Rathore, MD 4/21/17. Penetrating atherosclerotic ulcers of aorta Animesh Rathore, MD 4/21/17 Penetrating atherosclerotic ulcers of aorta Disclosures No financial disclosures Thank You Dr. Panneton for giving this lecture for me. I am stuck at Norfolk with an emergency

More information

Modified candy-plug technique for chronic type B aortic dissection with aneurysmal dilatation: a case report

Modified candy-plug technique for chronic type B aortic dissection with aneurysmal dilatation: a case report Kotani et al. Journal of Cardiothoracic Surgery (2017) 12:77 DOI 10.1186/s13019-017-0647-8 CASE REPORT Modified candy-plug technique for chronic type B aortic dissection with aneurysmal dilatation: a case

More information

THORACOABDOMINAL AORTIC ANEURYSMS HYBRID REPAIR

THORACOABDOMINAL AORTIC ANEURYSMS HYBRID REPAIR Update on Open and Endovascular Therapeutic Option for Aortic Repair CENTRE CARDIO-TORACIQUE DE MONACO Friday November 7 th, 2014 THORACOABDOMINAL AORTIC ANEURYSMS HYBRID REPAIR Roberto Chiesa Vascular

More information

P Paraplegia abdominal aortic aneurysm repair, 52 paraparesis, 52 pathophysiology, 51 rates and endografts, 51 two-stage approach, 129

P Paraplegia abdominal aortic aneurysm repair, 52 paraparesis, 52 pathophysiology, 51 rates and endografts, 51 two-stage approach, 129 A AAA. See Abdominal aortic aneurysm (AAA) Abdominal aortic aneurysm (AAA). See also Abdominal aortic pathologies advantage, IVUS, 20 asymptomatic infrarenal, 154 device selection and treatment, 19 20

More information

Asymptomatic Radiology / Clinical data Report / Cohort bias Referral bias. UCSF Vascular Symposium April 7-9, Acute Aortic Dissection

Asymptomatic Radiology / Clinical data Report / Cohort bias Referral bias. UCSF Vascular Symposium April 7-9, Acute Aortic Dissection Aortic Dissection: Natural History What is the Natural History of Aortic Dissection? UCSF Vascular Symposium April 7-9, 2011 Asymptomatic Radiology / Clinical data Report / Cohort bias Referral bias Stephen

More information

Management of intramural hematoma and penetrating ulcers - what is different? D.Böckler University Hospital Heidelberg, Germany

Management of intramural hematoma and penetrating ulcers - what is different? D.Böckler University Hospital Heidelberg, Germany Management of intramural hematoma and penetrating ulcers - what is different? D.Böckler University Hospital Heidelberg, Germany Disclosure Speaker name: Dittmar Böckler I have the following potential conflicts

More information

Is a Paradigm Shift towards Early Endovascular Treatment of Type B Dissection justified?

Is a Paradigm Shift towards Early Endovascular Treatment of Type B Dissection justified? Is a Paradigm Shift towards Early Endovascular Treatment of Type B Dissection justified? Dittmar Böckler Department of Vascular and Endovascular Surgery University of Heidelberg, Germany Disclosure Speaker

More information

Aortic dissection is one of the most catastrophic events that affects

Aortic dissection is one of the most catastrophic events that affects Surgery for Acquired Cardiovascular Disease Midterm results of stent-graft repair of acute and chronic aortic dissection with descending tear: The complicationspecific approach Noriyuki Kato, MD a Takatsugu

More information

The morbidity and mortality rates associated with the. Outcome of Surgical Treatment in Patients With Acute Type B Aortic Dissection

The morbidity and mortality rates associated with the. Outcome of Surgical Treatment in Patients With Acute Type B Aortic Dissection Outcome of Surgical Treatment in Patients With Acute Type B Aortic Dissection Tomoki Shimokawa, MD, Kazutaka Horiuchi, MD, Naomi Ozawa, MD, Kenu Fumimoto, MD, Susumu Manabe, MD, Tetsuya Tobaru, MD, and

More information

Technique and Outcome of Laser Fenestration For Arch Vessels

Technique and Outcome of Laser Fenestration For Arch Vessels Technique and Outcome of Laser Fenestration For Arch Vessels Jean M. Panneton MD, FRCSC, FACS Professor of Surgery Chief & Program Director Division of Vascular Surgery Eastern Virginia Medical School

More information

Endovascular surgery in Marfan syndrome: CON

Endovascular surgery in Marfan syndrome: CON Perspective Endovascular surgery in Marfan syndrome: CON Nicholas T. Kouchoukos Division of Cardiovascular and Thoracic Surgery, Missouri Baptist Medical Center, BJC Healthcare, St. Louis, Missouri, USA

More information

Reimbursement Guide Zenith Fenestrated AAA Endovascular Graft

Reimbursement Guide Zenith Fenestrated AAA Endovascular Graft MEDICAL Reimbursement Guide Zenith Fenestrated AAA Endovascular Graft Disclaimer: The information provided herein reflects Cook s understanding of the procedure(s) and/or device(s) from sources that may

More information

Complex Thoracic and Abdominal Aortic Repair Using Hybrid Techniques

Complex Thoracic and Abdominal Aortic Repair Using Hybrid Techniques Complex Thoracic and Abdominal Aortic Repair Using Hybrid Techniques Tariq Almerey MD, January Moore BA, Houssam Farres MD, Richard Agnew MD, W. Andrew Oldenburg MD, Albert Hakaim MD Department of Vascular

More information

Re-interventions after TEVAR:

Re-interventions after TEVAR: Re-interventions after TEVAR: How often does it occur and what are procedures most commonly utilized to treat these issues? Pacific Northwest Endovascular Conference Seattle, WA June 15, 2018 PENN Surgery

More information

Emerging Roles for Distal Aortic Interventions in Type A Dissection Surgery

Emerging Roles for Distal Aortic Interventions in Type A Dissection Surgery Emerging Roles for Distal Aortic Interventions in Type A Dissection Surgery Type A Dissection Workshop 2014 CCC Vancouver Oct 26 th, 2014 Jehangir Appoo Libin Cardiovascular Institute University of Calgary

More information

F. Terzi, S. Gianstefani, R. Fattori. cardiology and interventional cardiology unit, ospedali riuniti Marche nord, pesaro.

F. Terzi, S. Gianstefani, R. Fattori. cardiology and interventional cardiology unit, ospedali riuniti Marche nord, pesaro. 14_14 03/02/17 14.16 Pagina 101 Type B aortic dissection: it should Be TreaTed F. Terzi, S. Gianstefani, R. Fattori cardiology and interventional cardiology unit, ospedali riuniti Marche nord, pesaro.

More information

I have the following financial relationships to disclose:

I have the following financial relationships to disclose: Novel Approaches to Endovascular Management of Aortic Aneurysms Rodney A White, MD Medical Director, Vascular Services MemorialCare Heart & Vascular Institute Long Beach Memorial Hospital Long Beach, California

More information

WHICH PLACE FOR EMERGENT INTERVENTION IN COMPLICATED ACUTE TYPE B DISSECTION (ctbaod)

WHICH PLACE FOR EMERGENT INTERVENTION IN COMPLICATED ACUTE TYPE B DISSECTION (ctbaod) WHICH PLACE FOR EMERGENT INTERVENTION IN COMPLICATED ACUTE TYPE B DISSECTION (ctbaod) Epidemiology of type B Aortic Dissection TYPE B dissection: 0,5-2,1/100.000/year (40% of all dissection) Hospital mortality

More information

Are stent-grafts for acute type B dissection durable? Est-ce que les stents graft pour la dissection aigue de type B sont efficaces à moyen terme?

Are stent-grafts for acute type B dissection durable? Est-ce que les stents graft pour la dissection aigue de type B sont efficaces à moyen terme? Are stent-grafts for acute type B dissection durable? Est-ce que les stents graft pour la dissection aigue de type B sont efficaces à moyen terme? Martin Björck, Johnny Steuer, Anders Wanhainen Uppsala

More information

TEVAR for Chronic dissections: indications for TEVAR, long term results

TEVAR for Chronic dissections: indications for TEVAR, long term results TEVAR for Chronic dissections: indications for TEVAR, long term results J Sobocinski, R Azzaoui, B Maurel, R Spear, T Martin-Gonzalez, A Hertault, S Haulon Centre de l Aorte, Chirurgie vasculaire, Hôpital

More information

Transluminal placement of endovascular stentgrafts for the treatment of type A aortic dissection with an entry tear in the descending thoracic aorta

Transluminal placement of endovascular stentgrafts for the treatment of type A aortic dissection with an entry tear in the descending thoracic aorta CLINICAL RESEARCH STUDIES Transluminal placement of endovascular stentgrafts for the treatment of type A aortic dissection with an entry tear in the descending thoracic aorta Noriyuki Kato, MD, a Takatsugu

More information

Is there a way to predict the risk in uncomplicated Type B aortic dissections? FRANS MOLL University Medical Centre Utrecht - Netherlands

Is there a way to predict the risk in uncomplicated Type B aortic dissections? FRANS MOLL University Medical Centre Utrecht - Netherlands Is there a way to predict the risk in uncomplicated Type B aortic dissections? FRANS MOLL University Medical Centre Utrecht - Netherlands Disclosures: - Consultant Philips Health Care - Best Doctors Overview

More information

Clinical Outcome of Emergency Surgery for Complicated Acute Type B Aortic Dissection

Clinical Outcome of Emergency Surgery for Complicated Acute Type B Aortic Dissection Circulation Journal Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp ORIGINAL ARTICLE Cardiovascular Surgery Clinical Outcome of Emergency Surgery for Complicated Acute Type

More information

Dissection of descending aorta treated by stent-graft implantation in a patient with Marfan syndrome

Dissection of descending aorta treated by stent-graft implantation in a patient with Marfan syndrome Case Report 1 Dissection of descending aorta treated by stent-graft implantation in a patient with Marfan syndrome Marat. ripov, Ildar Z. bdyldaev, Semen D. Chevgun, ektur S. Daniyarov, Dinara. Toktosunova,

More information

Distal False Lumen Occlusion in Aortic Dissection With a Homemade Extra-Large Vascular Plug: The Candy-Plug Technique

Distal False Lumen Occlusion in Aortic Dissection With a Homemade Extra-Large Vascular Plug: The Candy-Plug Technique 484 J ENDOVASC THER 2013;20:484 489 TECHNICAL NOTE Distal False Lumen Occlusion in Aortic Dissection With a Homemade Extra-Large Vascular Plug: The Candy-Plug Technique Tilo Kölbel, MD, PhD; Christina

More information

RETROGRADE BRANCH. Gustavo S. Oderich MD Professor of Surgery Director of Endovascular Therapy Division of Vascular and Endovascular Surgery

RETROGRADE BRANCH. Gustavo S. Oderich MD Professor of Surgery Director of Endovascular Therapy Division of Vascular and Endovascular Surgery RETROGRADE BRANCH Gustavo S. Oderich MD Professor of Surgery Director of Endovascular Therapy Division of Vascular and Endovascular Surgery FACULTY DISCLOSURE Consulting* Cook Medical Inc., WL Gore Research

More information

Aortic Arch Treatment Open versus Endo Evidence versus Zeitgeist. M. Grabenwoger Dept. of Cardiovascular Surgery Hospital Hietzing Vienna, Austria

Aortic Arch Treatment Open versus Endo Evidence versus Zeitgeist. M. Grabenwoger Dept. of Cardiovascular Surgery Hospital Hietzing Vienna, Austria Aortic Arch Treatment Open versus Endo Evidence versus Zeitgeist M. Grabenwoger Dept. of Cardiovascular Surgery Hospital Hietzing Vienna, Austria Evidence Surgical aortic arch replacement with a Dacron

More information

Jean M Panneton, MD Professor of Surgery Program Director Vascular Surgery Chief EVMS. Arch Pathology: The Endovascular Era is here

Jean M Panneton, MD Professor of Surgery Program Director Vascular Surgery Chief EVMS. Arch Pathology: The Endovascular Era is here Jean M Panneton, MD Professor of Surgery Program Director Vascular Surgery Chief EVMS Arch Pathology: The Endovascular Era is here Disclosures Consultant: Cook Medical, Bolton Medical, Medtronic Inc, Volcano,

More information

Optimised management of type A aortic dissection with visceral malperfusion concept to reconsider

Optimised management of type A aortic dissection with visceral malperfusion concept to reconsider Optimised management of type A aortic dissection with visceral malperfusion concept to reconsider Matthias Thielmann, MD, PhD, FAHA Thoracic and Cardiovascular Surgery, West-German Heart and Vascular Center

More information

Aortic Arch/ Thoracoabdominal Aortic Replacement

Aortic Arch/ Thoracoabdominal Aortic Replacement Aortic Arch/ Thoracoabdominal Aortic Replacement Joseph S. Coselli, M.D. Vice Chair, Department of Surgery Professor, Chief, and Cullen Foundation Endowed Chair Division of Cardiothoracic Surgery Baylor

More information

Optimal repair of acute aortic dissection

Optimal repair of acute aortic dissection Optimal repair of acute aortic dissection Dept. of Vascular Surgery, The 2nd Xiang-Yale Hospital, Central-South University, China Hunan Major Vessels Diseases Clinical Center Chang Shu Email:changshu01@yahoo.com

More information

Research Article Propensity Score-Matched Analysis of Open Surgical and Endovascular Repair for Type B Aortic Dissection

Research Article Propensity Score-Matched Analysis of Open Surgical and Endovascular Repair for Type B Aortic Dissection Hindawi Publishing Corporation International Journal of Vascular Medicine Volume 2011, Article ID 364046, 7 pages doi:10.1155/2011/364046 Research Article Propensity Score-Matched Analysis of Open Surgical

More information

Follow-up of Aortic Dissection: How, How Often, Which Consequences Euro Echo 2011

Follow-up of Aortic Dissection: How, How Often, Which Consequences Euro Echo 2011 Follow-up of Aortic Dissection: How, How Often, Which Consequences Euro Echo 2011 Susan E. Wiegers, MD, FASE Director of Clinical Echocardiography Hospital of the University of Pennsylvania Disclosure

More information

Thoracic endovascular aneurysm repair for complicated type B aortic dissection

Thoracic endovascular aneurysm repair for complicated type B aortic dissection Jan D. Blankensteijn, MD, PhD, Section Editor EVIDENCE SUMMARY Thoracic endovascular aneurysm repair for complicated type B aortic dissection Christoph A. Nienaber, PhD, MD, a Stephan Kische, MD, a Hüseyin

More information

Therapeutic Pathway In Acute Aortic Dissection. Speaker: Cesare Quarto Consultant Cardiac Surgeon Royal Brompton Hospital, London UK

Therapeutic Pathway In Acute Aortic Dissection. Speaker: Cesare Quarto Consultant Cardiac Surgeon Royal Brompton Hospital, London UK Therapeutic Pathway In Acute Aortic Dissection Speaker: Cesare Quarto Consultant Cardiac Surgeon Royal Brompton Hospital, London UK Disclosure of Interest Speaker name: Cesare Quarto I do not have any

More information

Disclosures: Acute Aortic Syndrome. A. Michael Borkon, M.D. Director of CV Surgery Mid America Heart Institute Saint Luke s Hospital Kansas City, MO

Disclosures: Acute Aortic Syndrome. A. Michael Borkon, M.D. Director of CV Surgery Mid America Heart Institute Saint Luke s Hospital Kansas City, MO Acute Aortic Syndrome Disclosures: A. Michael Borkon, M.D. Director of CV Surgery Mid America Heart Institute Saint Luke s Hospital Kansas City, MO No financial relationships to disclose 1 Acute Aortic

More information

Antegrade Thoracic Stent Grafting during Repair of Acute Debakey I Dissection: Promotes Distal Aortic Remodeling and Reduces Late Open Re-operation

Antegrade Thoracic Stent Grafting during Repair of Acute Debakey I Dissection: Promotes Distal Aortic Remodeling and Reduces Late Open Re-operation Antegrade Thoracic Stent Grafting during Repair of Acute Debakey I Dissection: Promotes Distal Aortic Remodeling and Reduces Late Open Re-operation Vallabhajosyula, P: Szeto, W; Desai, N; Pulsipher, A;

More information

Endovascular Management of Thoracic Aortic Pathology Stéphan Haulon, J Sobocinski, B Maurel, T Martin-Gonzalez, R Spear, A Hertault, R Azzaoui

Endovascular Management of Thoracic Aortic Pathology Stéphan Haulon, J Sobocinski, B Maurel, T Martin-Gonzalez, R Spear, A Hertault, R Azzaoui Endovascular Management of Thoracic Aortic Pathology Stéphan Haulon, J Sobocinski, B Maurel, T Martin-Gonzalez, R Spear, A Hertault, R Azzaoui Aortic Center, Lille University Hospital, France Disclosures

More information

Surgical Considerations of TEVAR

Surgical Considerations of TEVAR Surgical Considerations of TEVAR University of Alberta, June 14 th, 2013 Jehangir Appoo Libin Cardiovascular Institute University of Calgary, Today: Lesions/Pathology amenable to TEVAR On label Off label

More information

I SECTION I. Thoracic aortic aneurysms

I SECTION I. Thoracic aortic aneurysms I SECTION I Thoracic aortic aneurysms 9 10 CASE 1 Endovascular repair of descending thoracic aortic aneurysms using the Gore TAG stent graft Introduction A descending thoracic aneurysm (DTA) is defined

More information

UC SF Early Intervention in Type B Dissection: Results From the INSTEAD XL Trial. Acute Type B Dissection. Outline. Disclosures.

UC SF Early Intervention in Type B Dissection: Results From the INSTEAD XL Trial. Acute Type B Dissection. Outline. Disclosures. Early Intervention in Type B Dissection: Results From the INSTEAD XL Trial None Disclosures Jade S. Hiramoto, MD, MAS April 4, 2014 Outline Background Current treatment Results from INSTEAD trial Results

More information

La sindrome aortica acuta oggi

La sindrome aortica acuta oggi University of Milan Thoracic Aortic Research Center La sindrome aortica acuta oggi Santi Trimarchi, MD, PhD Professore Associato di Chirurgia Vascolare, Università degli Studi di Milano Direttore, Divisione

More information

Type II arch hybrid debranching procedure

Type II arch hybrid debranching procedure Safeguards and Pitfalls Type II arch hybrid debranching procedure Prashanth Vallabhajosyula, Wilson Y. Szeto, Nimesh Desai, Caroline Komlo, Joseph E. Bavaria Division of Cardiovascular Surgery, University

More information

Residual Dissection and False Lumen Aneurysm After TEVAR

Residual Dissection and False Lumen Aneurysm After TEVAR WHAT WOULD YOU DO? Residual Dissection and False Lumen Aneurysm After MODERATOR: MARK FARBER, MD PANEL: YAZAN DUWAYRI, MD; MATTHEW J. EAGLETON, MD; WILLIAM D. JORDAN Jr, MD; TILO KÖLBEL, MD, PhD; AND ERIC

More information

Total Endovascular Repair Type A Dissection. Eric Herget Interventional Radiology

Total Endovascular Repair Type A Dissection. Eric Herget Interventional Radiology Total Endovascular Repair Type A Dissection Eric Herget Interventional Radiology 65 year old male Acute Type A Dissection Severe Aortic Regurgitation No co-morbidities Management? Part II Evolving Global

More information

Fate of Aneurysms of the Distal Arch and Proximal Descending Thoracic Aorta After Transaortic Endovascular Stent-Grafting

Fate of Aneurysms of the Distal Arch and Proximal Descending Thoracic Aorta After Transaortic Endovascular Stent-Grafting CARDIOVASCULAR Fate of Aneurysms of the Distal Arch and Proximal Descending Thoracic Aorta After Transaortic Endovascular Stent-Grafting Taijiro Sueda, MD, Kazumasa Orihashi, MD, Kenji Okada, MD, Yuji

More information

AORTIC DISSECTION. DISSECTING ANEURYSMS OF THE AORTA or CLASSIFICATION

AORTIC DISSECTION. DISSECTING ANEURYSMS OF THE AORTA or CLASSIFICATION DISSECTING ANEURYSMS OF THE AORTA or AORTIC DISSECTION CLASSIFICATION DeBakey classified aortic dissections into types I, II, and III :- Type I dissection the tear site originates in the ascending aorta,

More information

Thoracoabdominal Aorta: Advances and Novel Therapies

Thoracoabdominal Aorta: Advances and Novel Therapies Thoracoabdominal Aorta: Advances and Novel Therapies Robert Meisner, MD FACS Sidney Kimmel Medical Center Assistant Professor of Surgery Vascular / Endovascular Surgeon at Lankenau Medical Center November

More information

Primary to non-coronary IVUS

Primary to non-coronary IVUS codes 2018 2018 codes Primary to non-coronary IVUS Page 2 All coding, coverage, billing and payment information provided herein by Philips is gathered from third-party sources and is subject to change.

More information

Aortic remodeling after endovascular repair of acute complicated type B aortic dissection

Aortic remodeling after endovascular repair of acute complicated type B aortic dissection From the Eastern Vascular Society Aortic remodeling after endovascular repair of acute complicated type B aortic dissection Mark F. Conrad, MD, Robert S. Crawford, MD, Christopher J. Kwolek, MD, David

More information

Endovascular Treatment of Thoracic Aortic Disease. Four Years of Experience

Endovascular Treatment of Thoracic Aortic Disease. Four Years of Experience Endovascular Treatment of Thoracic Aortic Disease Four Years of Experience Alessandro S. Bortone, MD, PhD, FESC; Emanuela De Cillis, MD; Donato D Agostino, MD; Luigi de Luca Tupputi Schinosa, MD Background

More information

Accepted Manuscript. Is A More Extensive Operation Justified for Acute Type A Dissection Repair? Dr. Leonard N. Girardi

Accepted Manuscript. Is A More Extensive Operation Justified for Acute Type A Dissection Repair? Dr. Leonard N. Girardi Accepted Manuscript Is A More Extensive Operation Justified for Acute Type A Dissection Repair? Dr. Leonard N. Girardi PII: S0022-5223(18)32552-2 DOI: 10.1016/j.jtcvs.2018.09.048 Reference: YMTC 13502

More information

How to achieve a successful proximal sealing in TEVAR? Pr L Canaud

How to achieve a successful proximal sealing in TEVAR? Pr L Canaud How to achieve a successful proximal sealing in TEVAR? Pr L Canaud CHU de Montpellier France Disclosure I have the following potential conflicts of interest to report: Consulting: Medtronic. Proximal neck

More information